TRINITY HEALTH GRAND RAPIDS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $122K
- Transactions
- 58
- Companies
- 18
- Average per transaction
- $2,102
Who reported the payments
| Siemens Medical Solutions USA, Inc. | $42,555 |
| Mallinckrodt Enterprises LLC | $40,082 |
| Stryker | $5,766 |
| Boehringer Ingelheim | $5,585 |
| Johnson & Johnson | $5,053 |
| UCB, Inc. | $4,500 |
| Aesculap, Inc. | $3,463 |
| Zimvie Inc. | $2,627 |
| Alnylam Pharmaceuticals Inc. | $2,500 |
| Novo Nordisk | $2,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,000 |
| AstraZeneca | $1,599 |
| Amgen | $1,000 |
| Medtronic | $837 |
| Masimo Corporation | $796 |
| Organon | $700 |
| UCB SA | $333 |
| Sterilmed, Inc. | $32 |